Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03189173 · ClinicalTrials.gov registry record · Phase 2
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT03189173 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 41 participants.
The verdict
NCT03189173, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
The current study combines two treatments for obstructive sleep apnea (OSA), oral appliances and supplemental inspired oxygen. The following aims will be tested: Aim 1. To determine whether supplemental inspired oxygen further reduces OSA severity (apnea-hypopnea index) in patients using an oral appliance. Aim 2. To determine whether baseline OSA phenotypes can predict the efficacy of oral appliances versus supplemental oxygen versus both treatments in combination. We will test whether responders to oral appliances have distinct pathophysiological characteristics compared with oxygen responders.
Interventions
- DRUG Oxygen
- OTHER No treatment
- DEVICE Oral appliance
- OTHER Oral appliance plus oxygen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2017-09-06 |
| Est. Completion | 2023-05-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03189173
The ClinicalTrials.gov registry entry for NCT03189173 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Oxygen is the first listed.
NCT03189173 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03189173 about?
NCT03189173 is a clinical study titled "Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea". The current study combines two treatments for obstructive sleep apnea (OSA), oral appliances and supplemental inspired oxygen. The following aims will be tested: Aim 1. To determine whether supplemental inspired oxygen further reduces OSA severity (apnea-hypopnea index) in patients using an oral ap...
What is the current status of trial NCT03189173?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2017-09-06. Estimated completion is 2023-05-01.
What interventions are being tested in trial NCT03189173?
The interventions under investigation include: Oxygen (DRUG), No treatment (OTHER), Oral appliance (DEVICE), Oral appliance plus oxygen (OTHER).
Who is sponsoring clinical trial NCT03189173?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.